Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Biochemical Pharmacology
|
September 1, 2010
A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells
Leslie M Tompkins, Haishan Li, Linhao Li, et al.
Frontiers in Pharmacology
|
November 7, 2024
Identification of human pregnane X receptor antagonists utilizing a high-throughput screening platform
Caitlin Lynch, Ryan Margolis, Jacob Niebler, et al.
Scientific Reports
|
March 2, 2018
Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles
Ruili Huang, Menghang Xia, Srilatha Sakamuru, et al.
Molecules (Basel, Switzerland)
|
March 2, 2019
Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays
Caitlin Lynch, Jinghua Zhao, Srilatha Sakamuru, et al.
European Journal of Medicinal Chemistry
|
June 28, 2019
Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies
Dongdong Liang, Linhao Li, Caitlin Lynch, et al.
Toxicology and Applied Pharmacology
|
October 25, 2016
Differential modulation of FXR activity by chlorophacinone and ivermectin analogs
Chia-Wen Hsu, Jui-Hua Hsieh, Ruili Huang, et al.
Endocrinology
|
December 8, 2017
Identification of Estrogen-Related Receptor α Agonists in the Tox21 Compound Library
Caitlin Lynch, Jinghua Zhao, Ruili Huang, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 6, 2012
Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases
Zhimin Ou, Xiongjie Shi, Richard K Gilroy, et al.
Journal of Medicinal Chemistry
|
March 27, 2025
Potent and Selective Human Constitutive Androstane Receptor Activator DL5055 Facilitates Cyclophosphamide-Based Chemotherapies
Dongdong Liang, Linhao Li, Yong Ai, et al.
JCI Insight
|
May 17, 2022
Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment
Sydney Stern, Dongdong Liang, Linhao Li, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Biochemical Pharmacology
|
September 1, 2010
A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells
Leslie M Tompkins, Haishan Li, Linhao Li, et al.
Frontiers in Pharmacology
|
November 7, 2024
Identification of human pregnane X receptor antagonists utilizing a high-throughput screening platform
Caitlin Lynch, Ryan Margolis, Jacob Niebler, et al.
Scientific Reports
|
March 2, 2018
Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles
Ruili Huang, Menghang Xia, Srilatha Sakamuru, et al.
Molecules (Basel, Switzerland)
|
March 2, 2019
Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays
Caitlin Lynch, Jinghua Zhao, Srilatha Sakamuru, et al.
European Journal of Medicinal Chemistry
|
June 28, 2019
Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies
Dongdong Liang, Linhao Li, Caitlin Lynch, et al.
Toxicology and Applied Pharmacology
|
October 25, 2016
Differential modulation of FXR activity by chlorophacinone and ivermectin analogs
Chia-Wen Hsu, Jui-Hua Hsieh, Ruili Huang, et al.
Endocrinology
|
December 8, 2017
Identification of Estrogen-Related Receptor α Agonists in the Tox21 Compound Library
Caitlin Lynch, Jinghua Zhao, Ruili Huang, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 6, 2012
Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases
Zhimin Ou, Xiongjie Shi, Richard K Gilroy, et al.
Journal of Medicinal Chemistry
|
March 27, 2025
Potent and Selective Human Constitutive Androstane Receptor Activator DL5055 Facilitates Cyclophosphamide-Based Chemotherapies
Dongdong Liang, Linhao Li, Yong Ai, et al.
JCI Insight
|
May 17, 2022
Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment
Sydney Stern, Dongdong Liang, Linhao Li, et al.
Page
of 4